Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕ANGEL ONE NIFTY 50 ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaAngel One
NAV₹29.1863₹10.6742
NAV date20 Nov 202620 Nov 2026
History5.4 years1.5 years
Expense ratio0.2%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
1 month+10.82%+12.76%
3 months+7.43%+7.26%
6 months+14.54%+9.89%
YTD+25.40%−0.29%
1 year+25.57%−0.54%
3 years (CAGR)+22.02%—
5 years (CAGR)+16.60%—
10 years (CAGR)——
Since launch+14.02%+4.07%

Risk

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
Volatility15.0%—
Downside volatility9.0%—
Sharpe1.04—
Sortino1.72—
Calmar1.33—
Return / risk1.47—
Deepest fall−20.98%−15.07%
Days to recover136—
Below its high−1.75%−1.04%

Against benchmark

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
Alpha+0.00%—
Beta1.00—
R²100.0%—
Up capture100.0%—
Down capture100.0%—
Tracking error0.0%—
Information ratio——
Treynor0.14—

Consistency

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
Best 1-year+65.21%+2.03%
Middle 1-year+13.46%−3.48%
Worst 1-year−15.30%−11.79%
1-year periods with a loss25.8%92.5%
Middle 3-year+20.51%—
Positive months61.1%—
Best day+3.64%+3.77%
Worst day−4.03%−3.25%
Worst 5% day−1.62%−1.29%
Positive days54.4%51.1%
NAVs a year248247

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
5-year XIRR+20.60%—
5-year value₹10,11,738—
3-year XIRR+19.58%—
1-year XIRR+34.31%+11.13%

Holdings overlap i

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
Nippon India Nifty Pharma ETF—3%
ANGEL ONE NIFTY 50 ETF3%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
Sun Pharmaceutical Industries Limited18.61%1.76%
Dr. Reddy's Laboratories Limited8.15%0.77%
Cipla Limited7.67%0.73%

Sectors and company size

Nippon India Nifty Pharma ETFANGEL ONE NIFTY 50 ETF
Large companies45.3%98.5%
Mid companies47.1%1.4%
Small companies7.6%—
Top 10 holdings78.6%53.0%
Largest sectorPharmaceuticals & Biotechnology 100%Banks 30%

Search Growth